Investors jubilate as Immupharma rallies

PUBLISHED: 07 Apr 2018 @ 22:50 | Comments (0) | More info about Azeez Mustapha

Immuphaama shares (LSE:IMM) rallies significantly this week, and this has made investor’s to jubilate. Price moved upwards from November 2017 to January 2018, and then went southwards from February 2018 till early March 2018. But things have changed… in April.

Price is now above the EMA 21 and the William’s % Range period 20 is in the overbought region. This is a new phase – a bullish movement.

IMM is now in a bullish mode and price would go upwards to reach the supply zones at 200.00, 220.00 and 240.00.

Trading realities: Trading realities

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

Follow @ItuGlobal

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.